Premphase Kit
Product Images NDC 0046-2575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Premphase (NDC 0046-2575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prempro 01)

FDA Label Image

Figure 1 (Prempro 02)

FDA Label Image

Figure 2 (Prempro 03)

FDA Label Image

Figure 3 (Prempro 04)

FDA Label Image

Figure 4 (Prempro 05)

FDA Label Image

Logo (Prempro 06)

Logo (Prempro 06)
This is a text about a pharmaceutical company called Wyeth Pharmaceuticals LLC, which is a subsidiary of Pfizer Inc. The text mentions that this information is "distributed by". No further information is available.*
FDA Label Image

Logo (Prempro 06a)

Logo (Prempro 06a)
This text appears to be a brief description of a pharmaceutical product distribution company named "Wyeth Pharmaceuticals LLC", which is a subsidiary of "Pfizer Inc" located in Philadelphia, Pennsylvania.*
FDA Label Image

Principal Display Panel (28 Tablet 0.625 mg / 5 mg Blister Pack)

Principal Display Panel (28 Tablet 0.625 mg / 5 mg Blister Pack)
This is a medication that is available only with a prescription, as indicated by "Rx only". The medication comes in tablet form and has an NDC (National Drug Code) identifier of 0046267512. The directions for use instruct the user to start with the tablet labeled for Day 1 and take one maroon tablet daily for the first 14 days, followed by one light-blue tablet daily for the next 14 days. The medication should be stored at a temperature between 20°C and 25°C (68°F and 77°F), with excursions permitted up to 15°C to 30°C (59°F to 86°F). No information is available about the name or purpose of this medication.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
PREMPHASE is a medication that comes in a package of 28 tablets. Each blister card contains 14 maroon tablets of 0.625 mg conjugated estrogens and 5 mg medroxyprogesterone acetate. This medication is available only with a prescription.*
FDA Label Image

Principal Display Panel (0.3 mg / 1.5 mg Blister Card)

Principal Display Panel (0.3 mg / 1.5 mg Blister Card)
This is a description of Prempro, a medication containing conjugated estrogens and medroxyprogesterone acetate. The medication comes in tablet form, with each tablet containing 0.3mg of Premarin brand of conjugated estrogens and 1.5mg of medroxyprogesterone acetate. It is recommended to take one tablet daily until all tablets have been taken. The medication should be stored at a temperature of 20°C to 25°C, with excursions to 10°C to 30°C permitted. The medication packaging is not child-resistant, so it is important to keep it out of reach of children. It is distributed by Wyeth Pharmaceuticals, a subsidiary of Pfizer Inc. with lot and expiry information indicated.*
FDA Label Image

Principal Display Panel (0.3 mg / 1.5 mg Blister Card Carton)

Principal Display Panel (0.3 mg / 1.5 mg Blister Card Carton)
PREMPRO® is a medication composed of conjugated estrogens and medroxyprogesterone acetate tablets that come in 0.3mg/15mg strength. The package comes with one blister card of 28 tablets. The usual dosage is one tablet per day. The tablets should be stored at a controlled room temperature of 20-25°C (68-77°F), and kept away from children. The medication is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, and made in Ireland. More information can be found on www.PREMPRO.com.*
FDA Label Image

Principal Display Panel (0.45 mg / 1.5 mg Blister Card)

Principal Display Panel (0.45 mg / 1.5 mg Blister Card)
This is a product description for a medication called "PREMPRO" which is in tablet form (28 tablets per NDCD046-1106-11 package). The medication contains 0.45mg of Premarin (a brand of conjugated estrogen) and 1.5mg of medroxyprogesterone acetate. The directions for use advise taking one tablet per day as per the accompanying information. The packaging needs to be kept away from children. The medication is distributed by Wyeth Pharmaceuticals, a subsidiary of Pfizer Inc., and the lot number is XRO0KXX with expiration date MMM/YYYY. Storage at room temperature is recommended with some excursions permitted.*
FDA Label Image

Principal Display Panel (0.45 mg / 1.5 mg Blister Card Carton)

Principal Display Panel (0.45 mg / 1.5 mg Blister Card Carton)
Prempro is a medication containing conjugated estrogens and medroxyprogesterone acetate. It is available in tablets with 0.45mg of conjugated estrogens and 15mg of medroxyprogesterone acetate. Each package of Prempro includes 1 blister card with 28 tablets. The usual dosage is one tablet per day. Prempro should be stored at 20-25°C and kept out of the reach of children. Prempro is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. Made in Ireland. No additional information about the uses or effects of this medication is available.*
FDA Label Image

Principal Display Panel (0.625 mg / 2.5 mg Tablet Blister Card)

Principal Display Panel (0.625 mg / 2.5 mg Tablet Blister Card)
This is a description of Prempro tablets, which contains conjugated estrogens and medroxyprogesterone acetate, used for hormone replacement therapy. It is available in a package containing 28 peach-colored tablets, each with a strength of 0.625 mg of conjugated estrogens and 2.5 mg of medroxyprogesterone acetate. The directions indicate that one tablet should be taken daily until all tablets have been consumed. It should be stored at a temperature of 20° to 25°C, and children should not have access to it. The tablets are made in Ireland and distributed by Wyeth Pharmaceuticals, with a lot number and expiration date listed on the package.*
FDA Label Image

Principal Display Panel (0.625 mg / 2.5 mg Tablet Blister Card Carton)

Principal Display Panel (0.625 mg / 2.5 mg Tablet Blister Card Carton)
This is a description of Prempro, a prescription medication containing conjugated estrogens and medroxyprogesterone acetate tablets. The package contains 1 blister card of 28 tablets with a dose of 0.625mg /25mg. The usual dosage is one tablet per day, to be taken until all tablets have been consumed. The medication is stored between 20-25°C (68-77°F) and kept out of reach of children. It is distributed by Wyeth Pharmaceuticals LLC and manufactured in Ireland.*
FDA Label Image

Principal Display Panel (0.625 mg / 5 mg Tablet Blister Card)

Principal Display Panel (0.625 mg / 5 mg Tablet Blister Card)
This is a description of a medication called Prempro. It contains conjugated estrogens and medroxyprogesterone acetate and comes in the form of 28 tablets, with each tablet containing 0.625 mg of conjugated estrogens and 5 mg of medroxyprogesterone acetate. The instructions state to take one tablet per day until all tablets have been taken, with more detailed information provided in the accompanying instructions. The medication should be stored within a temperature range of 20°C to 25°C (68°F to 77°F), and the package is NOT child-resistant. The medication is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The rest of the text consists of lot and expiration information.*
FDA Label Image

Principal Display Panel (0.625 mg / 5 mg Tablet Blister Card Carton)

Principal Display Panel (0.625 mg / 5 mg Tablet Blister Card Carton)
PREMPRO® is a medication that comes in two dosages: 0.625 mg/5 mg and 0.625 mg/2.5 mg. The former comes in two blister cards of 26 tablets, and the latter comes in one blister card of 28 tablets. Each tablet contains conjugated estrogens and medroxyprogesterone acetate. PREMPRO® is a prescribed drug that should be taken daily until all tablets have been consumed, according to the enclosed instructions. This medication should be stored between 20-25°C (68-77°F) and should be kept out of reach of children. It also contains a note indicating that the packaging is not child-resistant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.